세계의 이식형 원격 환자 모니터링(IRPM) 디바이스 시장

The global market for implantable remote patient monitoring (IRPM) devices was valued at $6.5 billion in 2023. The market is expected to grow from $7.6 billion in 2024 to $20.3 billion by the end of 2029, at a compound annual growth rate (CAGR) of 21.7% from 2024 to 2029.

The North American market for IRPM devices is expected to grow from $2.7 billion in 2024 to $6.7 billion by the end of 2029, at a CAGR of 19.5% from 2024 to 2029.

The Asia-Pacific market for IRPM devices is expected to grow from $2.0 billion in 2024 to $5.9 billion by the end of 2029, at a CAGR of 24.3% from 2024 to 2029.

Report Scope

The current report provides detailed information about the market's implantable remote patient monitoring (IRPM) devices. It provides market projections through 2029 and market ranks for key players. The report details the market share of IRPM devices based on product, indication and end users. This market is segmented into implantable cardiovascular monitoring devices, implantable brain monitoring devices, gastrointestinal monitoring (smart pills), implantable hematological monitoring devices, implantable respiratory monitoring devices, implantable musculoskeletal monitoring devices and others based on product. Based on indication, the market is segmented into cardiovascular diseases, brain disorders, gastrointestinal diseases, diabetes, chronic respiratory diseases, musculoskeletal diseases, and others. By end user, the market is categorized into hospitals and clinics, home healthcare settings, and others. A detailed competitive landscape includes major players, market share and recent strategic developments.

Additionally, the report offers a regional analysis, breaking down market trends and growth prospects across different geographical areas. It includes market forecasts, consumer insights, and a thorough supply chain analysis, addressing distribution channels and key suppliers. By examining these elements, the report aims to provide a comprehensive view of the market's current state and future potential, assisting stakeholders in making well-informed decisions and identifying strategic opportunities within the IRPM devices industry.

Report Includes

• 32 data tables and 47 additional tables
• An overview of the global market for implantable remote patient monitoring (IRPM) devices
• Analyses of the global market trends, with sales data for 2021-2023, estimates for 2024, and projections of compound annual growth rates (CAGRs) through 2029
• Estimates of the market size and revenue forecast for the global market, and a corresponding market share analysis by product, indication, end user, and region
• Discussion of the underlying opportunities in the implantable remote patient monitoring devices market, with the integration of internet of things (IoT) and wireless technologies for the diagnosis and treatment of diseases
• Assessment of factors driving the industry's growth, current trends, market opportunities and restraints, and the technological advances that will shape the future market
• Market share analysis of the major global corporations, the competitive landscape, product developments, marketing strategies and revenue forecasts
• A discussion of the industry's ESG challenges and practices
• Emphasis on the increasingly stringent government regulations as well as the increasing adoption of miniaturized multi-sensing devices in chronic disease management and self-health management
• Latest information on mergers and acquisitions, partnerships, agreements, collaborations, and other strategic alliances
• Identification of the major stakeholders and analysis of recent developments and segmental revenues
• Profiles of the leading companies, including Boston Scientific Corp., Medtronic, Abbott Laboratories, Dexcom Inc., and Biotronik

Table of Contents

Chapter 1 Executive Summary

• Market Outlook
• Scope of Report
• Market Summary

Chapter 2 Market Overview

• Overview
• PESTEL Analysis
• Political
• Economic
• Social
• Technological
• Environmental
• Legal
• Porter's Five Forces Analysis
• Bargaining Power of Buyers
• Bargaining Power of Suppliers
• Potential for New Entrants
• Threat of Substitutes
• Competition in the Industry
• Supply Chain Analysis
• R&D, Product Design and Early Prototyping
• Regulatory Submissions and Approvals
• Raw Material Procurement
• Manufacturing IRPM Devices
• Distribution and Sales
• Post-Sales Services

Chapter 3 Market Dynamics

• Market Dynamics Overview
• Market Drivers
• Increasing Prevalence of Chronic Diseases and an Aging Population
• Growing Demand for mHealth Applications
• Improved Wireless Communication Technologies
• Market Restraints
• Data Privacy Concerns
• Stringent Government Regulations
• Market Opportunities
• Emerging Markets
• Market Challenges
• Integration with Healthcare Systems

Chapter 4 Regulatory Landscape

• Regulatory Framework
• United States
• European Union
• Japan

Chapter 5 Emerging Technologies and Developments

• Emerging Technologies in the IRPM Devices Market
• Artificial Intelligence and Machine Learning
• Nanotechnology-based Devices
• Biocompatible Materials
• Patent Analysis
• Patents by Year
• Patents by Top Applicant
• Patents by Top Owner
• Patents by Top Inventor
• Patents by Jurisdiction

Chapter 6 Market Segment Analysis

• Segmentation Breakdown
• IRPM Devices: Global Markets
• Market Analysis by Product
• Implantable Cardiovascular Monitoring Devices
• Implantable Brain Monitoring Devices
• Gastrointestinal Monitoring (Smart Pills)
• Implantable Hematological Monitoring Devices
• Implantable Respiratory Monitoring Devices
• Implantable Musculoskeletal Monitoring Devices
• Others
• Market Analysis by Indication
• Cardiovascular Diseases
• Brain Disorders
• Gastrointestinal Diseases
• Diabetes
• Chronic Respiratory Diseases
• Musculoskeletal Diseases
• Others
• Market Analysis by End User
• Hospital and Clinics
• Home Healthcare Settings
• Other End-users
• Geographic Breakdown
• Market Analysis by Region
• North America
• Europe
• Asia-Pacific
• Rest of the World

Chapter 7 Sustainability: An ESG Perspective in IRPM Devices

• Sustainability in the IRPM Devices Industry
• Understanding the ESG Data
• Concluding Remarks from BCC

Chapter 8 Competitive Intelligence

• Overview
• Key Strategies for IRPM Devices Manufacturers
• Distribution Networks
• Product Mapping

Chapter 9 Appendix

• Methodology
• Abbreviations
• Sources
• Company Profiles
• ABBOTT
• AVERTIX MEDICAL INC.
• BIOTRONIK
• BOSTON SCIENTIFIC CORP.
• CARDIAC RMS
• DEXCOM INC.
• EBR SYSTEMS INC.
• ENDOTRONIX INC.
• INJECTSENSE INC.
• IMPULSE DYNAMICS
• MEDICO S.R.L.
• MEDTRONIC
• PROFUSA INC.
• QURA LLC.
• VITALCONNECT